Pre-market hot trades in US stocks: SharpLink Gaming pre-market down 3.35%; Vertiv pre-market down 3.17%

Tracking Unusual Activity
2025.09.02 12:22
portai
I'm PortAI, I can summarize articles.

SharpLink Gaming pre-market down 3.35%; Vertiv pre-market down 3.17%; Carisma Therapeutics pre-market up 144.23%; Strata Skin Sciences pre-market up 76.47%; HWH pre-market up 75.00%

Pre-market Hot Trades in US Stocks

SharpLink Gaming is down 3.35% in pre-market trading. According to recent key news:

  1. On September 2, SharpLink Gaming's short interest rose to 36.18%, leading to increased bearish sentiment towards its stock. The company reported that shorted shares accounted for 10.54% of its float, which may exacerbate stock price volatility. Data source: Benzinga.

  2. On August 31, SharpLink Gaming held 797,700 ETH, valued at approximately $3.55 billion, with a 82% increase in holdings over the past 30 days, resulting in an unrealized gain of $753 million. This news indicates the company's strong financial position, which may positively impact its stock price. Data source: BlockBeats.

  3. On September 2, SharpLink increased its holdings by 39,008 Ethereum, bringing its total holdings to 837,230, valued at approximately $3.6 billion. This move demonstrates the company's continued investment in Ethereum, which may influence market confidence in its stock. Data source: Jinse Finance. The Ethereum treasury strategy has attracted market attention.

Vertiv is down 3.17% in pre-market trading. According to recent key news:

  1. On September 2, MarketBeat noted that although Vertiv was rated as a moderate buy by analysts, top analysts believe there are five stocks that are more worthy of investment, which may lead to a decline in investor confidence and affect the stock price.

  2. On August 31, MarketBeat's report did not list Vertiv as one of the top recommended stocks, which may negatively impact market sentiment.

  3. No other relevant events. Market sentiment is influenced by analyst recommendations.

Top Gainers in Pre-market US Stocks

Carisma Therapeutics is up 144.23% in pre-market trading. Based on recent key news:

  1. On August 29, Carisma Therapeutics announced significant breakthroughs in clinical trials for its new cancer treatment drug, leading to a substantial increase in stock price. The company stated that trial results showed its drug has significant efficacy in treating certain types of cancer, prompting a positive reaction from investors and driving the stock price up by 144.23%. The biotechnology sector has recently performed strongly, with increased policy support
Source: Tracking Unusual Activity The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.